Intelligent Bio Solutions Inc. (INBS)
USD 1.27
(-6.62%)
USD 1.27
(-6.62%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -8.81 Million USD | 7.0% |
| 2023 | -9.47 Million USD | 10.36% |
| 2022 | 30.82 Thousand USD | -16.33% |
| 2021 | -1.82 Million USD | -164.38% |
| 2020 | -561.18 Thousand USD | 59.79% |
| 2019 | -1.5 Million USD | -46.2% |
| 2018 | -416.91 Thousand USD | -2942.6% |
| 2017 | -151.28 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | -53.94% |
| 2024 Q1 | -2.21 Million USD | 14.53% |
| 2024 Q2 | -1.69 Million USD | 20.78% |
| 2024 Q3 | -2.71 Million USD | -63.89% |
| 2024 Q4 | -2.45 Million USD | 9.48% |
| 2023 Q4 | -2.47 Million USD | -20.65% |
| 2023 FY | - USD | 10.36% |
| 2023 Q3 | -2.04 Million USD | -18.26% |
| 2023 Q2 | -1.73 Million USD | -43.0% |
| 2023 Q1 | -1.21 Million USD | 41.92% |
| 2022 Q2 | -3.46 Million USD | -141.38% |
| 2022 Q4 | -2.08 Million USD | -55.58% |
| 2022 Q3 | -1.33 Million USD | 61.31% |
| 2022 Q1 | -1.43 Million USD | 37.78% |
| 2022 FY | - USD | -16.33% |
| 2021 Q4 | -2.3 Million USD | 26.4% |
| 2021 Q1 | -794.21 Thousand USD | -108.88% |
| 2021 Q2 | -916.89 Thousand USD | -15.45% |
| 2021 FY | - USD | -164.38% |
| 2021 Q3 | -3.13 Million USD | -241.68% |
| 2020 Q1 | -615.31 Thousand USD | 79.66% |
| 2020 FY | - USD | 59.79% |
| 2020 Q3 | -179.47 Thousand USD | 89.47% |
| 2020 Q4 | -380.23 Thousand USD | -111.86% |
| 2020 Q2 | -1.7 Million USD | -176.91% |
| 2019 Q3 | -1.44 Million USD | 0.0% |
| 2019 FY | - USD | -46.2% |
| 2019 Q4 | -3.02 Million USD | -109.45% |
| 2019 Q1 | -1.5 Million USD | 16.02% |
| 2018 Q3 | -756.14 Thousand USD | 0.0% |
| 2018 Q4 | -1.79 Million USD | -137.19% |
| 2018 FY | - USD | -2942.6% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 95.875% |
| Prenetics Global Limited | -47.89 Million USD | 81.605% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -422.271% |
| CareDx, Inc | -89.65 Million USD | 90.173% |
| Exact Sciences Corporation | 41.87 Million USD | 121.04% |
| Exagen Inc. | -19.15 Million USD | 53.998% |
| Inotiv, Inc. | -26.5 Million USD | 66.76% |
| Guardant Health, Inc. | -433.3 Million USD | 97.967% |
| Biodesix, Inc. | -37.1 Million USD | 76.253% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -254.533% |
| Precipio, Inc. | -4.31 Million USD | -104.046% |
| iSpecimen Inc. | -9.1 Million USD | 3.219% |
| Natera, Inc. | -383.27 Million USD | 97.701% |
| Aspira Women's Health Inc. | -16.49 Million USD | 46.573% |
| Standard BioTools Inc. | -54.45 Million USD | 83.821% |
| 23andMe Holding Co. | -291.87 Million USD | 96.981% |
| Castle Biosciences, Inc. | -45.02 Million USD | 80.431% |
| Personalis, Inc. | -96.8 Million USD | 90.899% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 92.506% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | 8.136% |
| OpGen, Inc. | -29.51 Million USD | 70.144% |
| T2 Biosystems, Inc. | -43.87 Million USD | 79.919% |
| Myriad Genetics, Inc. | -67.8 Million USD | 87.005% |
| ICON Public Limited Company | 1.63 Billion USD | 100.54% |
| NeoGenomics, Inc. | -17.6 Million USD | 49.959% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -422.271% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 100.724% |
| RadNet, Inc. | 292.78 Million USD | 103.009% |
| MDxHealth SA | -30.46 Million USD | 71.082% |
| Psychemedics Corporation | -251 Thousand USD | -3410.242% |
| Illumina, Inc. | -608 Million USD | 98.551% |
| Check-Cap Ltd. | -17.64 Million USD | 50.078% |
| Twist Bioscience Corporation | -176.7 Million USD | 95.014% |
| DarioHealth Corp. | -53.49 Million USD | 83.53% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 81.073% |
| Sera Prognostics, Inc. | -35.28 Million USD | 75.031% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | 9.955% |
| OPKO Health, Inc. | -65.51 Million USD | 86.552% |
| Medpace Holdings, Inc. | 363.15 Million USD | 102.426% |
| Neogen Corporation | 182.59 Million USD | 104.825% |
| Prenetics Global Limited | -47.89 Million USD | 81.605% |
| Mainz Biomed B.V. | -25.01 Million USD | 64.773% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -15.485% |
| Trinity Biotech plc | -24.09 Million USD | 63.438% |
| Neuronetics, Inc. | -22.75 Million USD | 61.287% |
| Sotera Health Company | 514.14 Million USD | 101.714% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -15.485% |